St Phi Therapeutics Company
Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies.
Employee Number:
11-50
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2017-01-01
Industry:
Advanced BioTech R&D
Sub-Industry:
Gene Therapies (Diseases Treatment)
Investors:
Shenzhen Capital Group, Panacea Venture, Tao Capital Partners, Teda Venture Capital, Tailong Investment
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China